This report contains market size and forecasts of Apatinib in global, including the following market information:
Global Apatinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Apatinib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Apatinib companies in 2021 (%)
The global Apatinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.25g/Pcs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Apatinib include Advenchen Laboratories, Jiangsu Hengrui Medicine, LSK BioPartners and Bukwang Pharmaceutical Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Apatinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Apatinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Apatinib Market Segment Percentages, by Type, 2021 (%)
0.25g/Pcs
0.425g/Pcs
0.375g/Pcs
Global Apatinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Apatinib Market Segment Percentages, by Application, 2021 (%)
Metastatic Gastric Carcinoma
Metastatic Breast Cancer
Advanced Hepatocellular Carcinoma
Other
Global Apatinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Apatinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Apatinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Apatinib revenues share in global market, 2021 (%)
Key companies Apatinib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Apatinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advenchen Laboratories
Jiangsu Hengrui Medicine
LSK BioPartners
Bukwang Pharmaceutical Company